Nathan Pickett, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1250 New State Hwy, Raynham, MA 02767 Phone: 508-825-6800 Fax: 508-386-0585 |
Kassandra Varney, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 675 Paramount Dr Ste 301, Raynham, MA 02767 Phone: 508-880-2417 |
Meaghan Hannagan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1470 New State Hwy, Raynham, MA 02767 Phone: 774-202-9206 |
News Archive
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its expanded offering of Powerlink® stent graft products. The approval covers 31 new sizes of Powerlink® main body bifurcated, proximal extension, and limb extension stent grafts that increase the system's addressable patient population by 5% to 10%.
Cornell University researchers report they have discovered direct genetic evidence that a family of genes, called MicroRNA-34 (miR-34), are bona fide tumor suppressors.
The costs of drinking and driving are all too apparent, with alcohol involved in 41 percent of all motor vehicle crash fatalities in 2006. In addition to the mortality and morbidity associated with drinking and driving, the economic impact of alcohol impaired driving is considerable, estimated at $51 billion, with medical costs accounting for 15 percent of that figure.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today positive top-line results of a Phase 1 study of PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin and immediate-release omeprazole.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
› Verified 7 days ago